Key facts
- PetIQ’s last known valuation is $1.4B (Oct 2024).
- It has raised $650.0M; the latest was PE Growth/Expansion in Apr 2025.
- Notable investors include Ares Management, Bansk Group.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for PetIQ
- ·The full record, as it builds
Funding rounds
No funding rounds for PetIQ are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PetIQ
Provider of pet health and wellness products and services designed to improve access to affordable care. The company offers a broad portfolio of prescription medications, over-the-counter treatments, and wellness products, as well as veterinary services through retail-based community clinics and wellness centres, thereby enabling pet owners to conveniently maintain the health and well-being of their pets.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Eagle, ID, United States
- Founded
- 2010
- Employees
- 1,933
- Website
- petiq.com/
- Ownership
- Privately Held (backing)
PetIQ doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PetIQ shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PetIQ in its N-PORT filings yet. We sweep new filings monthly.